top of page
Lab Image.jpg

Biology Is Only Limited by Our Own Imagination Today

Building on advances in genomics, machine learning, engineering, and manufacturing, Alexis Bio’s patented platform unlocks the greatest manufacturer of all: Nature.


Alexis Bio is applying nature’s insights to code biological solutions starting with our body’s primary immune barrier – our skin… and that’s just the beginning.

Here’s What our Engineers, Scientists,

and Leaders are Delivering Today

realSKIN White Logo 2023 Reg Mark.png
Skin Burn Icon.png

realSKIN® by Alexis Bio is the first live biotherapeutic skin transplant to complete a Phase I/2 Clinical Trial and the first to receive both U.S. FDA Orphan Drug and Regenerative Medicine Advance Therapy (RMAT) Designations. Partnering burn centers believe that realSKIN® will become an important medical countermeasure for the treatment of severe burns.


Nerves Icon.png

realNERVE™ by Alexis Bio is under peer-review in a major medical journal reporting findings from a large preclinical series evaluating the safety and efficacy of a novel live biotherapeutic nerve transplant. There is an unmet need for large gap peripheral nerve damage and realNERVE™ offers a new solution to help restore a patient’s quality of life.


Tissues Icon.png

realTISSUE™ involves the transplantation of multiple structures that may include cells, bone grafts, blood vessels, valves

and connective tissue. 

"If the misery of our poor be caused not by the laws of nature, but by our institutions, great is our sin."

- Charles Darwin

bottom of page